Nitazoxanide

Nitazoxanide for Treatment of Cryptosporidium in Children

AGILE (Early Phase Platform Trial for COVID-19)

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children

Nitazoxanide in Patients With Ulcerative Colitis

NNITS-Nitazoxanide for Norovirus in Transplant Patients Study

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Treatment of Cryptosporidiosis

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Nitazoxanide in Patients With Metastatic Colorectal Cancer

Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy Volunteers

Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus

Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19